dihexa cancer risk hgf c met The HGF/c-Met Axis: A Promising Therapeutic Target in Anti-cancer therapeutic strategies based on
Anti cancer therapeutic strategies based on HGF MET, EpCAM, and tumor stromal cross talk Cancer Cell International Springer Nature Link c Met Signaling as a Therapeutic Target in Head : The Cancer Journal Therapeutic Strategies for Ovarian Cancer in Point of HGF c MET Targeting dihexa c met cancer risk Developing pathway inhibitors for therapy: progress and challenges: Trends in Molecular Medicine Activated HGF c Met Axis in Head Targeting HGF c MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion Cell Communication and Signaling Springer Nature Link
Pay in 4 interest-free payments of $5.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6



